An aspirin a day reduces melanoma risk
For years, doctors have been prescribing a daily dose aspirin to lower the risk of heart attack and stroke. More recently aspirin has proven effective in lowering the risk of colon cancer.
A new study from researchers at Beth Israel Deaconess Medical Center and the Dana Farber Cancer Institute suggests that long-term aspirin use may also significantly lower the risk of cutaneous melanoma, the most deadly form of skin cancer.
"The incidence of cutaneous melanoma continues to climb faster than other common cancers," says Dr. Robert Stern, BIDMC's Chief of Dermatology. "Prevention strategies other than sunscreen and reduced sun exposure may help reduce this incidence."
For more, click here.